Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Safety Study of ARRY-371797 in Healthy Subjects.

Trial Profile

A Safety Study of ARRY-371797 in Healthy Subjects.

Phase of Trial: Phase I

Latest Information Update: 23 Apr 2012

At a glance

  • Drugs ARRY 797 (Primary)
  • Indications Ankylosing spondylitis; Cancer; Dental pain; Musculoskeletal pain; Rheumatoid arthritis
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 23 Apr 2012 Actual patient number 40 added as reported by ClinicalTrials.gov.
    • 09 Feb 2009 New source identified and integrated (ClinicalTrials.gov): planned end date is now 1 Jan 2009.
    • 25 Nov 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top